CXCL12 and osteosarcoma: In osteosarcoma, epigenetically downregulated CXCL12 via DNA methyltransferase 1 (DNMT1) impairs CD8 + killer T cell homing to the tumour sites, consequently, metastatic cells evade immune mediated cytotoxicity [353].